Owe orwar biography

We are proud to have been recognised by StartUp City Magazine as one of the most promising European Biotech startups in 2019!

Press release

Oblique Therapeutics has been recognized as one of the 15 most promising Biotech startups in Europe 2019, by StartUp City magazine

Gothenburg, Sweden, July 17, 2019 – Oblique Therapeutics, a Swedish biotech focusing on generating novel therapeutic antibodies towards severe diseases such as cancer and pain, has been honored as one of the most promising biotech startup in Europe 2019 by StartUp City magazine. An interview with the CEO, Owe Orwar is featured on the cover story of the BioTech special issue published this month.

StartUp City Magazine: “Oblique Therapeutics is uncovering medical breakthroughs in antibody therapeutics using its proporietary technology platform AbiprotTM ”. The AbiprotTM technology enables the development of antibodies against difficult-to-drug targets such as ion channels and certain G-protein-coupled receptors ( Owe orwar biography images.